Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients (SAVE-O2)
Critical Illness, Wounds and Injury, Disease Attributes
About this trial
This is an interventional treatment trial for Critical Illness focused on measuring hypoxia, hyperoxia, trauma, burn, critical illness, supplemental oxygen, oxygenation, SpO2, PaO2, FiO2, normoxia, hypoxemia, normoxemia, hyperoxemia
Eligibility Criteria
Inclusion Criteria:
- Acutely injured patients who meet the criteria for entry into the state or national trauma registry
- Admission to surgical/trauma ICU within 24 hours of hospital arrival
Exclusion Criteria:
- Age <18 years
- Prisoners
- Known pregnancy
- Transferred patients not admitted through the emergency department
Sites / Locations
- University of Alabama-Birmingham Medical Center
- Denver Health
- University of Cincinnati Medical Center
- Oregon Health and Sciences University
- University of Pittsburgh Medical Center
- Vanderbilt University Medical Center
- Brooke Army Medical Center
- The University of Texas Health Science Center at Houston
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Pre-Implementation
Post-Implementation Targeting Normoxemia in Trauma ICU
The control (pre-implementation) group will be trauma patients admitted to the surgical/trauma ICU during the site's control period of the stepped-wedge implementation process (up to 22 months).
The intervention (post-implementation) group will be patients admitted to the surgical/trauma ICU during the targeted normoxemia intervention period of the stepped-wedge implementation process (up to 25 months).